Albany, New York USA (PRWEB) April 12, 2014
High growth rate in emerging markets, technological advancements, strong support from governments and other active associations like WHO and GAVI, and increased investment in research and development are all leading to the overall growth of the vaccine production market. The vaccine production market is expected to exhibit improved performance in the coming years due to the successful launch of new vaccines.
Browse the full report with request TOC at
Vaccines for different illnesses are among the top revenue earners in the pharmaceutical industry. Research and development in this field is leading to the production of improved and effective vaccines for various illnesses. Substantial revenue growth in the vaccine production market in recent years shows the increasing enormity of this industry.
Vaccine Production Market Segmentation
Vaccine production market is segmented as follows:
Both, adult and pediatric segments have a constant growth momentum. The major players have been formulating strategies to enlarge their global presence in the vaccine production market.
This report analyzes the industry growth rate¸ current trends, and industry structure. It includes the study of current developments in the vaccine production market, Porter’s five force analysis, and detailed profiles of the top industry players. This report provides a detailed review of macro and micro factors significant for the existing market players and new entrants along with value chain analysis.
The major geographies studied under this research are North America, Europe, Asia-Pacific, and the Rest of the World.
The key players dominating this market are GlaxoSmithKline Biopharmaceuticals, Sanofi Aventis, Merck KgaA, Pfizer-Pfizer CenterSource, Novartis AG, Baxter International, Teva, Crucell (Johnson & Johnson), Intercell, CSL Biotherapies, MassBioLogics, MedImmune/ Astra Zeneca, and others.
Vaccine production is also done on contractual basis. Major players involved in manufacturing vaccines on contractual basis are Boehringer Ingelheim, Fujifilm Diosynth Biotechnology, Catalent Pharma Solutions, Patheon, Cambrex, Lonza, IDT Biologika, Charles River Biopharmaceutical Services (BPS), and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
Reasons for Buying this Report